Table 1: Contributing groups to the HDFCCC strategic plan.
Groups 1 and 2 were extant groups; Group 3 was convened for the purposes of Phase 1 of the planning process and then disbanded.
| (1) CCSG Programs | (2a) Site Committees | (2b) Developing Initiatives | (3) Thematic Task Forces |
|---|---|---|---|
| Breast Oncology Cancer Control Cancer Genetics Cancer Immunology Experimental Therapeutics Hematopoietic Malignancies Neurologic Oncology Pediatric Malignancies Prostate Cancer Tobacco Control |
Breast Cutaneous/Melanoma Cancer Control Cancer Immunotherapy Experimental Therapeutics Gastrointestinal (GI) Genitourinary (GU) Gynecology Hematopoietic Metabolic Imaging and Radioisotope Therapy Neurologic Oral, Head, and Neck Pediatric Radiation Oncology Symptom Management Thoracic |
Geriatric Oncology Global Cancer Integrative Oncology Survivorship and Symptom Science Theranostics |
Understanding the Mechanisms of Cancer (etiology) Preventing Cancer Detecting and Diagnosing Cancer Developing Cancer Cures Delivering Heath Care to All Developing Tools to Study Cancer |